Exercise Dose Halts Cognitive Decline in Parkinson's

Long-term tracking data in neurodegenerative care consistently reveals an uncomfortable reality: pharmaceutical interventions manage tremors and rigidity far better than they protect cognition. A seven-year longitudinal study tracking Parkinson's patients shows that physical activity directly counters this trajectory. Participants who logged more than eight hours of moderate-to-vigorous exercise per week experienced almost zero average cognitive decline over seven years, while maintaining higher baseline motor stability than sedentary counterparts.

The finding shifts exercise from a generic supportive habit to a measured therapeutic protocol. In neurodegenerative conditions, dopamine depletion in the striatum gradually degrades executive function, planning, and working memory alongside primary motor symptoms. High-volume aerobic movement stimulates brain-derived neurotrophic factor, sustaining synaptic plasticity across cortical networks that routine drug therapy leaves unaddressed.

Treating movement as neuroprotective medicine requires objective accounting. If you manage early Parkinson's or care for someone who does, ignore vague instructions to stay active. Audit your weekly movement logs through a basic smartwatch or cycling computer to determine whether your actual output approaches that eight-hour line, then review the distribution with your neurologist.